Back

Watch Compare

Cosmos Health Inc.

Data quality: 100%

COSM

NASDAQ Wholesale Trade Nondurable Goods Wholesale

$0.33

▲ $0.01 (2.61%)

6 months return

—

Momentum

Neutral

5Y revenue growth

-0.45%

Growth

Revenue Growth (5Y)

-0.45%

Below sector avg (3.59%)

Revenue (1Y)1.97%

Earnings (1Y)N/A

FCF Growth (3Y)N/A

Quality

Return on Equity

-75.12%

Below sector avg (-4.23%)

ROIC-36.57%

Net Margin-31.01%

Op. Margin-23.86%

Safety

Debt / Equity

0.23

Below sector avg (0.32)

Current Ratio0.99

Interest Coverage-9.12

Valuation

PE (TTM|NTM)

-0.58 | -2.73

Below sector avg (-0.17)

P/B Ratio0.47

EV/EBITDAN/A

Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Revenue declined -0.45% annually over 5 years

Debt/Equity of 0.23 — conservative balance sheet

Negative free cash flow of -7.81 M

Capital efficient — spends only 0.20% of revenue on capex

Price History

Financial Trends

Analyst Price Target

1 analyst

Hold

+1247.3%

upside to target

Current

$0.33

Consensus Target

$4.50

Low

$4.50

High

Forecast

Forward P/E

-2.73

Forward EPS

-$0.11

Est. Revenue

98.60 M

Earnings Surprises

EPS

Reported Estimate Forecast

Next: Q1 2026 · EPS Est: -$0.07 · Rev Est: 20.70 M

	Q32025	Q1 '26
Reported	-$0.17	—
Estimate	—	-$0.07
Surprise	—	—

Growth

Rev 5Y: -0.45% · Earnings 1Y: N/A

Revenue Growth (1Y)	1.97%	Revenue Growth (3Y)	3.97%
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	-0.45%	Earnings Growth (5Y)	N/A

Profitability

ROE: -75.12% · Net Margin: -31.01%

Revenue (TTM)	59.79 M	Net Income (TTM)	-18.54 M
ROE	-75.12%	ROA	-28.24%
Gross Margin	11.41%	Operating Margin	-23.86%
Net Margin	-31.01%	Free Cash Flow (TTM)	-7.81 M
ROIC	-36.57%	FCF Growth (3Y)	N/A

Safety

D/E: 0.23 · Current: 0.99

Debt / Equity	0.23	Current Ratio	0.99
Interest Coverage	-9.12	Asset Turnover	0.91
Working Capital	-430,028	Tangible Book Value	15.17 M

Dividends

Yield: N/A · Payout: N/A

Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A

Valuation

P/E: -0.58 · EV/EBITDA: N/A

P/E Ratio	-0.58	Forward P/E	-2.73
P/B Ratio	0.47	P/S Ratio	0.18
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	N/A	Fwd EV/EBITDA	N/A
Forward P/S	0.11	Fwd Earnings Yield	N/A
FCF Yield	-72.24%
Market Cap	10.80 M	Enterprise Value	15.28 M

Per Share

EPS: -0.77 · FCF/Share: -0.21

EPS (Diluted TTM)	-0.77	Revenue / Share	1.60
FCF / Share	-0.21	OCF / Share	-0.21
EPS CAGR (1Y)	N/A	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A

Efficiency

FCF Conv: 42.10% · CapEx/Rev: 0.20%

CapEx / Revenue	0.20%	FCF Conversion	42.10%
SBC-Adj. FCF	-9.96 M	Growth Momentum	2.42

Income Statement

Annual, most recent first

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	54.43 M	53.38 M	50.35 M	56.24 M	55.41 M
Net Income	-16.18 M	-18.54 M	-13.83 M	-7.96 M	820,786.0
EPS (Diluted)	-1.17	-2.15	-33.16	-0.95	0.06
Gross Profit	4.31 M	4.35 M	5.96 M	8.33 M	8.06 M
Operating Income	-15.54 M	-21.83 M	-7.47 M	-4.53 M	2.71 M
EBITDA	—	—	—	—	—
R&D Expenses	533,293.0	—	—	—	—
SG&A Expenses	—	—	—	—	—
D&A	1.25 M	614,377.0	103,194.0	449,692.0	397,595.0
Interest Expense	1.01 M	866,476.0	2.35 M	2.82 M	3,910.0
Income Tax	0.0	-775,051.0	775,051.0	-114,010.0	377,535.0

Balance Sheet

Annual, most recent first

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Total Assets	54.31 M	66.01 M	68.04 M	49.43 M	43.84 M
Total Liabilities	29.78 M	29.97 M	28.38 M	45.05 M	48.01 M
Shareholders' Equity	24.53 M	36.04 M	39.28 M	4.38 M	-4.16 M
Total Debt	4.11 M	4.61 M	5.02 M	17.91 M	10.77 M
Cash & Equivalents	—	—	20.75 M	286,487.0	628,395.0
Current Assets	25.46 M	36.61 M	56.04 M	40.88 M	40.77 M
Current Liabilities	25.76 M	24.32 M	21.75 M	29.93 M	34.79 M

Peer Comparison

vs Wholesale Trade sector median (100 peers)

Metric	Stock	Sector Median
P/E	-0.6	-0.2
P/B	0.5	1.0
ROE %	-75.1	-4.2
Net Margin %	-31.0	-2.7
Rev Growth 5Y %	-0.5	3.6
D/E	0.2	0.3